Table 1 Patient demographics and clinical characteristics
QW | EDS | |
|---|---|---|
(n = 374) | (n = 378) | |
Sex, n (%) | ||
Men | 148 (40) | 126 (33) |
Women | 226 (60) | 252 (67) |
Race, n (%) | ||
White | 301 (80) | 309 (82) |
Black or African American | 41 (11) | 41 (11) |
Hispanic or Latino | 21 (6) | 12 (3) |
Asian | 5 (1) | 7 (2) |
Japanese | 2 (1) | 1 (<1) |
Other | 4 (1) | 8 (2) |
Mean (SD) age, years | 62.4 (12.5) | 62.8 (13.0) |
95% CI | 61.2, 63.7 | 61.5, 64.2 |
Age ≥65 years, n (%) | 177 (47) | 180 (48) |
Age ≥75 years, n (%) | 68 (18) | 80 (21) |
Primary tumor type, n (%) | ||
Breast | 100 (27) | 112 (30) |
Lung | 91 (24) | 101 (27) |
Gastrointestinal | 89 (24) | 72 (19) |
Gynecologic | 29 (8) | 30 (8) |
Leukemia | 26 (7) | 22 (6) |
Genitourinary | 17 (5) | 20 (5) |
Othera | 22 (6) | 21 (6) |
Patients with stage IV cancer, n (%)b | 183 (52) | 179 (50) |
Mean (SD) baseline Hbc (g/dL) | 10.1 (0.9) | 10.1 (0.8) |